Rigel Pharmaceuticals (RIGL) FCF Margin (2010 - 2026)
Rigel Pharmaceuticals' (RIGL) quarterly FCF Margin came in at 4.63% in Q1 2026, up 631.0% year-on-year from 0.63% in Q1 2025, and down 85.29% quarter-over-quarter from 31.49% in Q4 2025.
Rigel Pharmaceuticals (RIGL) FCF Margin (2010 - 2026) Analysis & Trends
Rigel Pharmaceuticals' FCF Margin history runs 16 years deep, the most recent figure standing at 4.63% for Q1 2026.
- On a quarterly basis, FCF Margin rose 631.0% year-over-year to 4.63% in Q1 2026; TTM through Mar 2026 was 26.44%, a 892.0% increase from a year earlier, with the FY2025 full-year figure at 25.71%, up 815.0% from the prior year.
- FCF Margin eased to 4.63% in Q1 2026 per RIGL's latest filing, from 31.49% in the prior quarter.
- Across five years, FCF Margin topped out at 39.2% in Q3 2024 and bottomed at 154.53% in Q1 2022.
- The 5-year median for FCF Margin is 1.67% (2025), against an average of 9.82%.
- Across the five-year window, FCF Margin plunged 25155 bps in 2022 and jumped 13928 bps in 2023, its largest moves.
- Year by year, FCF Margin stood at 44.56% in 2022, then jumped by 61 bps to 17.52% in 2023, then soared by 244 bps to 25.18% in 2024, then grew by 25 bps to 31.49% in 2025, then sank by 85 bps to 4.63% in 2026.
- Per Business Quant, the three latest RIGL FCF Margin figures stand at 4.63% (Q1 2026), 31.49% (Q4 2025), and 34.6% (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 10.45% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 43.35% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 23.53% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Rigel Pharmaceuticals | 674.25 Mn | 527.57 Mn | 54.21 Mn | 4.63% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.63% |
| Dec 31, 2025 | 31.49% |
| Sep 30, 2025 | 34.60% |
| Jun 30, 2025 | 30.03% |
| Mar 31, 2025 | -1.67% |
| Dec 31, 2024 | 25.18% |
| Sep 30, 2024 | 39.20% |
| Jun 30, 2024 | 0.82% |
| Mar 31, 2024 | -16.97% |
| Dec 31, 2023 | -17.52% |
| Sep 30, 2023 | -4.88% |
| Jun 30, 2023 | 22.06% |
| Mar 31, 2023 | -15.25% |
| Dec 31, 2022 | -44.56% |
| Sep 30, 2022 | -56.33% |
| Jun 30, 2022 | -43.18% |
| Mar 31, 2022 | -154.53% |
| Dec 31, 2021 | -91.08% |
| Sep 30, 2021 | -48.59% |
| Jun 30, 2021 | 208.38% |